Pyxis Oncology Inc.

NASDAQ: PYXS · Real-Time Price · USD
1.21
0.08 (7.08%)
At close: Aug 15, 2025, 3:59 PM
1.21
0.00%
After-hours: Aug 15, 2025, 07:37 PM EDT

Pyxis Oncology Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
3.4M 19.55M 19.57M 19.57M 19.57M 3.42M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost of Revenue
2.29M 3.88M 2.94M 3.62M 3.73M 2.47M 2.17M 2M 1.78M 1.84M 1.69M 1.49M 1.02M 626K 312K 410K 410K
Gross Profit
1.12M 15.67M 16.63M 15.95M 15.84M 947K -2.17M -2M -1.78M -1.84M -1.69M -1.49M -1.02M -626K -312K -410K -410K
Operating Income
-106.77M -89.46M -67.16M -68.76M -66.85M -82.2M -102.4M -105.44M -113.05M -123.48M -101.93M -85.16M -65.38M -69.72M -57.87M -49.44M -46.06M
Interest Income
6.73M 7.04M 7.01M 6.87M 6.51M 6.63M 6.91M 5.92M 4.43M 2.76M 899K 186K 28K 23K 16K 11K 37.5K
Pretax Income
-97.4M -79.5M -57.36M -59.2M -57.8M -73.79M -94.29M -98.92M -108.58M -120.72M -101.44M -87.95M -70.53M -75.97M -63.73M -52.74M -47.12M
Net Income
-95.23M -77.33M -57.36M -59.2M -57.8M -72.08M -33.6M -37.5M -47M -60.84M -100.55M -87.77M -70.52M -75.97M -63.73M -52.74M -47.12M
Selling & General & Admin
23.04M 25.42M 26.5M 31.15M 31.8M 32.61M 34.57M 33.26M 35.09M 37.35M 38.43M 32.85M 27.03M 18.66M 10.9M 7.9M 5.98M
Research & Development
63.88M 58.75M 54.45M 51.4M 48.84M 48.82M 67.83M 72.18M 77.96M 86.13M 63.5M 52.32M 38.35M 51.05M 46.97M 41.54M 40.08M
Other Expenses
20.96M 20.96M n/a 598K 1.16M 1.2M 1.2M 602K 38K n/a n/a n/a n/a n/a n/a n/a n/a
Operating Expenses
85.25M 82.5M 80.95M 82.55M 80.64M 81.43M 102.4M 105.44M 113.05M 123.48M 101.93M 85.16M 65.38M 69.72M 57.87M 49.44M 46.06M
Interest Expense
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 6K 10K 10K 10K 4K
Selling & Marketing Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
106.77M 105.61M 83.3M 84.9M 82.99M 82.2M 102.4M 105.44M 113.05M 123.48M 101.93M 85.16M 65.38M 69.72M 57.87M 49.44M 46.06M
Income Tax Expense
-2.16M -2.16M n/a n/a n/a -1.71M -60.7M -61.42M -61.58M -59.88M -892K -173K -9K n/a n/a -1K -1K
Shares Outstanding (Basic)
61.05M 60.72M 60.72M 60.5M 51.29M 44.75M 41.33M 38.39M 35.35M 34.96M 32.56M 32.45M 32.32M 31.73M 31.73M 31.73M 22.13M
Shares Outstanding (Diluted)
61.05M 60.72M 60.72M 60.5M 51.29M 44.75M 41.33M 38.39M 35.35M 34.96M 32.56M 32.45M 32.32M 31.73M 31.73M 31.73M 22.13M
EPS (Basic)
-1.34 -1.05 -1.05 -1.26 -1.38 -1.82 -0.82 -1.09 -1.46 -1.93 -3.11 -2.73 -2.21 -2.9 -2.58 -2.27 -4.75
EPS (Diluted)
-1.34 -1.05 -1.05 -1.26 -1.38 -1.82 -0.82 -1.09 -1.46 -1.93 -3.11 -2.73 -2.21 -2.9 -2.58 -2.27 -4.75
EBITDA
-84.52M -66.1M -64.05M -66.38M -64.47M -80.7M -101.98M -104.82M -112.27M -122.77M -101.51M -84.78M -64.93M -69.32M -57.21M -48.67M -45.49M
EBIT
-62.89M -68.5M -67.16M -68.76M -66.85M -82.16M -102.36M -105.4M -113.01M -123.48M -101.93M -85.16M -65.38M -69.72M -57.87M -49.44M -46.06M
Depreciation & Amortization
1.87M 2.98M 3.19M 3.14M 3.25M 2.47M 2.17M 2M 1.78M 1.84M 1.69M 1.49M 1.23M 956K 812K 910K 708K